ANI PHARMACEUTICALS INC
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board
ANI Pharmaceuticals (NasdaqGM: ANIP) appointed biotechnology executive Henry Gosebruch to its Board of Directors. Gosebruch previously held leadership roles at Lakefront Biotherapeutics, Neumora Therapeutics, and AbbVie. Board member Muthusamy (Samy) Shanmugam resigned from the Board and will continue in key operational roles at ANI Pharmaceuticals. This kind of board refresh is not unique to ANI Pharmaceuticals, and investors who want broader exposure to companies shaped closely by their...
ANI Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
Moby summary of ANI Pharmaceuticals, Inc.'s Q2 2026 earnings call
Congressional Trades in $ANIP
No disclosed congressional trades found in $ANIP.
Insider Trades (Form 4)
Thoma Jeanne
Cook Meredith
Gutwerg Ori
CAREY STEPHEN P.
Cook Meredith
Key People
Thoma Jeanne
Director
Gutwerg Ori
SVP, GENERICS
CAREY STEPHEN P
SVP & CFO
CAREY STEPHEN P
SVP & CFO
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro